These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32271831)

  • 1. Economic burden of venous thromboembolism in surgical patients: A propensity score analysis from the national claims database in Vietnam.
    Bui MH; Le QC; Duong DH; Nguyen TS; Tran BG; Duong TD; Tran TH; Nguyen HC; Kieu TTM; Nguyen HH; Hoang L; Nguyen TB; Pham TV; Hoang THX
    PLoS One; 2020; 15(4):e0231411. PubMed ID: 32271831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.
    Blin P; Samama CM; Sautet A; Benichou J; Lignot-Maleyran S; Lamarque S; Lorrain S; Lassalle R; Droz-Perroteau C; Mismetti P; Moore N
    Pharmacol Res; 2019 Mar; 141():201-207. PubMed ID: 30583081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Inpatient Venous Thromboembolism Continues After Discharge: Retrospective Propensity Scored Analysis in a Longitudinal Database.
    Li AY; Azad TD; Veeravagu A; Bhatti I; Li A; Cole T; Desai A; Ratliff JK
    Clin Spine Surg; 2017 Dec; 30(10):E1392-E1398. PubMed ID: 27750270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspective.
    Casciano JP; Dotiwala Z; Kemp R; Li C; Cai J; Preblick R
    Am J Health Syst Pharm; 2015 Feb; 72(4):291-300. PubMed ID: 25631836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study.
    Sepassi A; Chingcuanco F; Gordon R; Meier A; Divino V; DeKoven M; Ben-Joseph R
    J Med Econ; 2018 Jun; 21(6):595-602. PubMed ID: 29480088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
    Grosse SD; Nelson RE; Nyarko KA; Richardson LC; Raskob GE
    Thromb Res; 2016 Jan; 137():3-10. PubMed ID: 26654719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective administrative database study of the time period of venous thromboembolism risk during and following hospitalization for major orthopedic or abdominal surgery in real-world US patients.
    Amin AN; Lenhart G; Princic N; Lin J; Thompson S; Johnston S
    Hosp Pract (1995); 2011 Apr; 39(2):7-17. PubMed ID: 21576893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US.
    Amin A; Deitelzweig S; Bucior I; Lin J; Lingohr-Smith M; Menges B; Neuman WR
    J Med Econ; 2019 Nov; 22(11):1119-1125. PubMed ID: 31084383
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.
    Farias-Eisner R; Horblyuk R; Franklin M; Lunacsek OE; Happe LE
    Curr Med Res Opin; 2009 May; 25(5):1081-7. PubMed ID: 19298219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism.
    Coleman CI; Baugh C; Crivera C; Milentijevic D; Wang SW; Lu L; Nelson WW
    J Med Econ; 2017 Feb; 20(2):200-203. PubMed ID: 27780397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause and disease-related health care costs associated with recurrent venous thromboembolism.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S
    Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
    Baser O; Supina D; Sengupta N; Wang L; Kwong L
    Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients.
    Gussoni G; Foglia E; Frasson S; Casartelli L; Campanini M; Bonfanti M; Colombo F; Porazzi E; Ageno W; Vescovo G; Mazzone A;
    Thromb Res; 2013 Jan; 131(1):17-23. PubMed ID: 23141845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Neuraxial Anesthesia With Postoperative Venous Thromboembolism After Noncardiac Surgery: A Propensity-Matched Analysis of ACS-NSQIP Database.
    Turan A; Bajracharya GR; Leung S; Yazici Kara M; Mao G; Botsford T; Ruetzler K; Maheshwari K; Ali Sakr Esa W; Elsharkawy H; Sessler DI
    Anesth Analg; 2019 Mar; 128(3):494-501. PubMed ID: 29697506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital risk of venous thromboembolism and bleeding and associated costs for patients undergoing total hip or knee arthroplasty.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2012; 15(4):644-53. PubMed ID: 22356512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature.
    Laskov I; Kessous R; Abitbol J; Kogan L; Badeghiesh A; Tagalakis V; Cohen S; Salvador S; Lau S; Gotlieb WH;
    J Obstet Gynaecol Can; 2018 Dec; 40(12):1571-1579. PubMed ID: 30262383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Venous Thromboembolism and Operative Duration in Patients Undergoing Neurosurgical Procedures.
    Bekelis K; Labropoulos N; Coy S
    Neurosurgery; 2017 May; 80(5):787-792. PubMed ID: 28327952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.
    Streiff M; Milentijevic D; McCrae KR; Laliberté F; Lejeune D; Lefebvre P; Schein J; Khorana AA
    J Med Econ; 2019 Nov; 22(11):1134-1140. PubMed ID: 31106638
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting venous thromboembolism following laparoscopic bariatric surgery: development of the BariClot tool using the MBSAQIP database.
    Dang JT; Switzer N; Delisle M; Laffin M; Gill R; Birch DW; Karmali S
    Surg Endosc; 2019 Mar; 33(3):821-831. PubMed ID: 30003351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.